作者
Mengling Wu, Qianrui Huang, Mengya Liao, Xuyi Wu, Huizhi Xi, Hongbo Ma, Shanrui Li, Yiwen Zhang, Yong Xia
发表日期
2022/12
期刊
Cellular Oncology
卷号
45
期号
6
页码范围
1255-1275
出版商
Springer Netherlands
简介
Purpose
Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer. As yet, chemotherapy with drugs such as doxorubicin is the main treatment strategy. However, drug resistance and dose-dependent toxicities restrict their clinical use. Natural products are major sources of anti-tumor drugs. OSW-1 is a natural compound with strong anti-cancer effects in several types of cancer, but its effects on the efficacy of chemotherapy in TNBC and its underlying mechanism remain unclear.
Methods
The inhibitory activities of OSW-1 and its combination with several chemotherapy drugs were tested using in vitro assays and invivo subcutaneous and metastatic mouse TNBC models. The effects of the mono- and combination treatments on TNBC cell viability, apoptosis, autophagy and related signaling pathways were assessed using MTT, flow cytometry, RNA sequencing and immunology-based assays …
学术搜索中的文章
M Wu, Q Huang, M Liao, X Wu, H Xi, H Ma, S Li… - Cellular Oncology, 2022